Qin DENG, Ruoqiu FU, Ning GAO. Cepharanthine inhibits autophagic degradation in breast cancer MDA-MB-231 cells[J]. Journal of Third Military Medical University, 2017, 39(24): 2352-2358.
DOI:
Qin DENG, Ruoqiu FU, Ning GAO. Cepharanthine inhibits autophagic degradation in breast cancer MDA-MB-231 cells[J]. Journal of Third Military Medical University, 2017, 39(24): 2352-2358. DOI: 10.16016/j.1000-5404.201709083.
Cepharanthine inhibits autophagic degradation in breast cancer MDA-MB-231 cells
To investigate the effect of cepharanthine on autophagy in breast cancer MDA-MB-231 cells.
Methods
2
Confocal laser scanning microscopy was used to observe the formation of autophagosome and autophagic flux in breast cancer MDA-MB-231 cells after the transfection with EGFP-LC3 or tfLC3 plasmids. Western blot analysis was used to detect the expression of autophagy related proteins
including LC3B
p62 and Beclin1. Confocal laser scanning microscopy was used to observe the LysoTracker staining and the co-localization of autophagosome (mRFP-LC3) and lysosome (mGFP-LAMP1). Western blot analysis was also used to detect the expression of lysosomal-associated membrane proteins LAMP1 and LAMP2.
Results
2
The number of EGFP-LC3 puncta in the cells treated with cepharanthine was significantly greater than that in control cells (30.40±6.42
vs
5.00±2.12
P
<
0.01)
and the expression levels of LC3B-Ⅱ and p62 were increased in a dose-and time-dependent manner. Exposure to
cepharanthine and bafilomycin A1 caused pronounced formation of LC3 puncta that displayed both green and red fluorescence intensity producing a yellow overlay after transfected with tfLC3. In contrast
the cells exposed to rapamycin led to the production of large amounts of red-only puncta. Cepharanthine combined with bafilomycin A1 did not show any significant increase in the accumulation of LC3B-Ⅱ and p62. In contrast
treatment with rapamycin resulted in a slight increase in the levels of LC3B-Ⅱ that were further enhanced by cepharanthine treatment. Furthermore
treatment with rapamycin resulted in decreased p62 levels that were markedly reversed by cepharanthine treatment. Further studies indicated that cepharanthine did not affect lysosomal staining nor decrease the expression of LAMP1 and LAMP2
but it affected the colocalization of mRFP-LC3 and mEGFP-LAMP1.
Conclusion
2
Cepharanthine inhibits autophagic degradation in breast cancer MDA-MB-231 cells through blocking autophagosome-lysosome fusion.
关键词
Keywords
references
YEDJOU C, IZEVBIGIE E, TCHOUNWOU P. Preclinical assessment of vernonia amygdalina leaf extracts as DNA damaging Anti-cancer agent in the management of breast cancer[J]. Int J Environ Res Public Health, 2008, 5(5): 337-341.
CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338.
ZHOU J, LI G B, ZHENG Y, et al. Liensinine inhibits autophagy in breast cancer MDA-MB-231 cells[J]. J Third Mil Med Univ, 2015, 37(7): 629-633. DOI:10.16016/j.1000-5404.201411115.
BAUER K R, BROWN M, CRESS R D, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype[J]. Cancer, 2007, 109(9): 1721-1728. DOI: 10.1002/cncr.22618.
DESANTIS C E, LIN C C, MARIOTTO A B, et al. Cancer treatment and survivorship statistics, 2014[J]. CA Cancer J Clin, 2014, 64(4): 252-271. DOI: 10.3322/caac.21235.
JANKU F, MCCONKEY D J, HONG D S, et al. Autophagy as a target for anticancer therapy[J]. Nat Rev Clin Oncol, 2011, 8(9): 528-539. DOI: 10.1038/nrclinonc.2011.71.
LIANG D H, CHOI D S, ENSOR J E, et al. The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair[J]. Cancer Lett, 2016, 376(2): 249-258. DOI: 10.1016/j.canlet.2016.04.002.
VALSECCHI M E, KIMMEY G, BIR A, et al. Role of carboplatin in the treatment of triple negative early-stage breast cancer[J]. Rev Recent Clin Trials, 2015, 10(2): 101-110. DOI: 10.2174/1574887110666150624101343.
LU Y A. Cepharanthine prevention of leukopenia induced by anticancer drugs in clinical experience[J]. Foreign Med Sci: Pharmaceut Sci, 1976(5): 296-297. DOI: 10.13220/j.cnki.jipr.1976.05.013.
PAZYAR N, JAMSHYDIAN N. Cepharanthine: a therapeutic potential candidate for psoriasis[J]. J Altern Complement Med, 2012, 18(7): 639-640. DOI: 10.1089/acm.2012.0314.
PENG Y M, WANG N, WANG Y F, et al. Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells[J]. Acta Pharm Sin, 2012, 47(5): 594-599. DOI: 10.16438/j.0513-4870.2012.05.015.
GANLEY I G, LAM DU H, WANG J, et al. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy[J]. J Biol Chem, 2009, 284(18): 12297-12305. DOI: 10.1074/jbc.M900573200.
ROSENFELD M R, YE X, SUPKO J G, et al. A phase Ⅰ/Ⅱ trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme[J]. Autophagy, 2014, 10(8): 1359-1368. DOI: 10.4161/auto.28984.
CYNTHIA I, CHUDE, RAVI K. Targeting autophagy in cancer: update on clinical trials and novel inhibitors[J]. Int J Mol Sci, 2017, 18(6): 1279. DOI: 10.3390/ijms1806 1279.
KREUZALER P, WATSON C J. Killing a cancer: what are the alternatives[J]. Nat RevCancer, 2012, 12(6): 411-424. DOI: 10.1038/nrc3264.
HUANG H, HU G, WANG C, et al. Cepharanthine, an alkaloid from stephania cepharantha hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models[J]. Inflammation, 2014, 37(1): 235-246. DOI: 10. 1007/s10753-013-9734-8.
SU Y H, LI H L.Anti-Arrhythmic effects of L-stepholidine[J]. J Kunming Med Univ, 2009, 30(10): 23-25.
ROGOSNITZKY M, DANKS R. Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions[J]. Pharmacol Rep, 2011, 63(2): 337-347.
HUA P, SUN M, ZHANG G, et al. Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells[J]. Biochem Biophys Res Commun, 2015, 460(2): 136-142. DOI: 10.1016/j.bbrc.2015.02.131.
SEUBWAI W, VAETEEWOOTTACHARN K, HIYOSHI M, et al. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB [J]. Cancer Sci, 2010, 101(7): 1590-1595. DOI: 10.1111/j.1349-7006.2010. 01572.x.
LAW B Y, MOK S W, CHAN W K, et al. Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers[J]. Oncotarget, 2016, 7(7): 8090-8104. DOI: 10.18632/oncotarget.6980.
REGGIORI F, UNGERMANN C. Autophagosome maturation and fusion[J]. J Mol Biol, 2017, 429(4): 486-496. DOI: 10.1016/j.jmb.2017.01.002.
NAKAMURA S, YOSHIMORI T. New insights into autophagosome-lysosome fusion[J].J Cell Sci, 2017, 130(7): 1209-1216. DOI: 10.1242/jcs.196352.